The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.80
Bid: 12.10
Ask: 13.00
Change: 0.80 (6.81%)
Spread: 0.90 (7.438%)
Open: 12.50
High: 12.50
Low: 11.80
Prev. Close: 11.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Consolidation & Tucson Facility Closure

14 Feb 2024 07:00

RNS Number : 0343D
Carclo plc
14 February 2024
 

14 February 2024

 

Carclo plc

 

Strategic Consolidation and Closure of Tucson Facility

 

Ossett, February 14, 2024 - Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation, and production to assembly and printing, serving the life sciences, aerospace, optics, and tech sectors, announces the strategic closure of its Tucson, AZ facility. This decision represents the culmination of our US restructuring efforts, aimed at optimizing our operational footprint and aligning closely with our strategic objectives.

 

In alignment with this closure, Carclo is taking significant steps to enhance operational efficiency and customer service. The majority of manufacturing volumes from the Tucson site are being relocated to our state-of-the-art facilities in Pennsylvania, USA. This move not only consolidates our technical and manufacturing expertise but also brings production closer to our Design & Engineering center, fostering innovation and efficiency.

 

Furthermore, Carclo is leveraging its global footprint to redistribute manufacturing capacity. This strategic reallocation is designed to position our production facilities closer to our customer bases, thereby improving service levels, reducing lead times, and facilitating more sustainable operations.

 

Employee Impact

Carclo is committed to supporting them through comprehensive transition assistance programs for the employees affected, including job placement services, counselling, and career transition resources.

 

Strategic Benefits and Future Direction

This restructuring is a key component of Carclo's strategy to achieve operational excellence, financial stability, and sustainable growth. By concentrating our operations, we aim to enhance our competitive edge, innovate more effectively, and provide superior value to our customers and stakeholders.

 

Commitment to Stakeholders

Carclo remains deeply committed to supporting all stakeholders through this transition. Detailed plans are in place to ensure a seamless transfer of operations, with minimal disruption to our customers and supply chain partners. We are dedicated to upholding the high standards of service and quality that define Carclo.

 

Enquiries

For further information or enquiries regarding this announcement, please contact:

 

Carclo plc - 01924 268040

Frank Doorenbosch - Chief Executive Officer

Eric Hutchinson - Chief Financial Officer

 

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a preferred and trusted partner of global customers, offering high-precision critical components that meet the needs of life sciences, aerospace, optics, and technology industries.

 

LEI: 21380078MEM399JPI956

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXADFLNLEFA
Date   Source Headline
26th Feb 20197:00 amRNSHolding(s) in Company
22nd Feb 201910:52 amRNSHolding(s) in Company
19th Feb 20199:39 amRNSAppointment of Chief Operating Officer
19th Feb 20199:16 amRNSHolding(s) in Company
7th Feb 20193:32 pmRNSHolding(s) in Company
6th Feb 20195:57 pmRNSHolding(s) in Company
6th Feb 20191:57 pmRNSHolding(s) in Company
6th Feb 20191:56 pmRNSHolding(s) in Company
6th Feb 201911:51 amRNSHolding(s) in Company
6th Feb 201911:51 amRNSDirector/PDMR Shareholding
31st Jan 201911:12 amRNSHolding(s) in Company
16th Jan 201912:37 pmRNSHolding(s) in Company
16th Jan 201911:43 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSTrading Statement
21st Nov 20182:49 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSHalf-year Report
12th Oct 20187:00 amRNSTrading Update
29th Aug 20185:08 pmRNSHolding(s) in Company
13th Aug 201811:39 amRNSDirector/PDMR Shareholding
9th Aug 20188:08 amRNSForm 8.3 - [Carclo plc]
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
8th Aug 20188:46 amRNSForm 8.3 - [Carclo plc]
7th Aug 20181:46 pmRNSHolding(s) in Company
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201810:36 amRNSForm 8.3 - [Carclo plc]
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 20182:52 pmRNSDirector/PDMR Shareholding
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 20189:47 amRNSForm 8 (DD) - Carclo
1st Aug 20189:41 amRNSForm 8 (DD) - Carclo
1st Aug 20189:38 amRNSPerformance Share Plan
1st Aug 20188:19 amRNSForm 8.3 - [Carclo plc]
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
31st Jul 201811:01 amRNSForm 8 (DD) - Carclo
31st Jul 201810:54 amRNSDirector/PDMR Shareholding
31st Jul 20189:27 amRNSForm 8.3 - [Carclo plc]
30th Jul 20181:49 pmRNSForm 8.3 - [Carclo plc]
30th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
30th Jul 201811:48 amRNSForm 8 (DD) - Carclo
27th Jul 20182:38 pmRNSForm 8.3 - [Carclo plc]
27th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.